on behalf of the Antimicrobial Stewardship in Cancer Consortium ASCC
on behalf of the Antimicrobial Stewardship in Cancer Consortium ASCC Search for other papers by on behalf of the Antimicrobial Stewardship in Cancer Consortium ASCC in Current site Google Scholar PubMedClose
BakerTM, SatlinMJ. The growing threat of multidrug-resistant Gram-negative infections in patients with hematologic malignancies. Leuk Lymphoma2016;57:2245–2258.
BakerTM, SatlinMJ. The growing threat of multidrug-resistant Gram-negative infections in patients with hematologic malignancies. Leuk Lymphoma 2016;57:2245–2258.10.1080/10428194.2016.119385927339405)| false
RoutyB, Le ChatelierE, DerosaL, et al.. Gut microbiome influences efficacy of PD-1-based immunotherapy against epithelial tumors. Science2018;359:91–97.
RoutyB, Le ChatelierE, DerosaL, . Gut microbiome influences efficacy of PD-1-based immunotherapy against epithelial tumors. Science 2018;359:91–97.10.1126/science.aan370629097494)| false
Society for Healthcare Epidemiology of AmericaInfectious Diseases Society of AmericaPediatric Infectious Diseases Society. Policy statement on antimicrobial stewardship by the Society for Healthcare Epidemiology of America (SHEA), the Infectious Diseases Society of America (IDSA), and the Pediatric Infectious Diseases Society (PIDS). Infect Control Hosp Epidemiol2012;33:322–327.
Society for Healthcare Epidemiology of AmericaInfectious Diseases Society of AmericaPediatric Infectious Diseases Society. Policy statement on antimicrobial stewardship by the Society for Healthcare Epidemiology of America (SHEA), the Infectious Diseases Society of America (IDSA), and the Pediatric Infectious Diseases Society (PIDS). Infect Control Hosp Epidemiol 2012;33:322–327.)| false
BarlamTF, CosgroveSE, AbboLM, et al.. Implementing an antibiotic stewardship program: Guidelines by the Infectious Diseases Society of America and the Society for Healthcare Epidemiology of America. Clin Infect Dis2016;62:e51–e77.
BarlamTF, CosgroveSE, AbboLM, . Implementing an antibiotic stewardship program: Guidelines by the Infectious Diseases Society of America and the Society for Healthcare Epidemiology of America. Clin Infect Dis 2016;62:e51–e77.)| false
RobilottiE, HolubarM, SeoSK, et al.. Feasibility and applicability of antimicrobial stewardship in immunocompromised patients. Curr Opin Infect Dis2017;30:346–353.
Aguilar-GuisadoM, EspigadoI, Martín-PeñaA, et al.. Optimisation of empirical antimicrobial therapy in patients with haematological malignancies and febrile neutropenia (How Long study): an open-label, randomised, controlled phase 4 trial. Lancet Haematol2017;4:e573–e583.
MicallefC, AliyuSH, SantosR, et al.. Introduction of an antifungal stewardship programme targeting high-cost antifungals at a tertiary hospital in Cambridge, England. J Antimicrob Chemother2015;70:1908–1911.
MicallefC, AliyuSH, SantosR, . Introduction of an antifungal stewardship programme targeting high-cost antifungals at a tertiary hospital in Cambridge, England. J Antimicrob Chemother 2015;70:1908–1911.)| false
